ETFS Holding Sanofi

 
ETF Quotes for ETFS Holding Sanofi top ^
  • Holdings: Total SA , Sanofi , BNP Paribas , LVMH Moet Hennessy Louis Vuitton SA , AXA SA ,
Sign-up for ewq investment picks
  • Holdings: Total SA , Bayer AG , Sanofi , Banco Santander SA , Siemens AG ,
  • Morningstar Rating: 1 Stars
Sign-up for ezu investment picks
  • Holdings: Total SA , Bayer AG , Sanofi , Banco Santander SA , Siemens AG ,
  • Morningstar Rating: 1 Stars
Sign-up for fez investment picks
  • Holdings: Novartis AG , Roche Holding AG Dividend Right Cert. , Bayer AG , Sanofi , GlaxoSmithKline PLC ,
  • Morningstar Rating: 1 Stars
Sign-up for iry investment picks

 
Stock Quotes for Sanofi top ^
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Mid Growth
Sign-up for 500674 investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for san investment picks

 
News Articles for Sanofi top ^
Sanofi Announces $2.5 Million Contribution to Dementia Research Canada NewsWire MONTREAL , Sept.
Sign-up for Sanofi Announces $2.5 Million Contribution to Dementia Research investment picks
2014/9/9
Sanofi Canada launching YouTube Channel Canada NewsWire LAVAL, QC , Sept.
Sign-up for Sanofi Canada launching YouTube Channel investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some of the companies whose shares made notable moves in European trade on Thursday.
Sign-up for UPDATE: RBS, Lloyds climb; Sanofi slips: Europe's big stock moves investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some of the companies whose shares made notable moves in European trade on Thursday.
Sign-up for RBS, Lloyds climb; Sanofi slips: Europe's big stock moves investment picks
2014/9/17
- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments - PARIS and SOUTH SAN FRANCISCO, Calif.
Sign-up for Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease investment picks
VALENCIA, Calif., Sept.
Sign-up for MannKind Announces Closing of Global Licensing Agreement With Sanofi investment picks
TARRYTOWN, N.Y. and PARIS , Sept.
Sign-up for Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps investment picks
2014/10/6
Unilife to be the sole provider of wearable injectors for all of Sanofi's applicable large dose volume drugs YORK, Pa.
Sign-up for Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors with Sanofi investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational pediatric hexavalent vaccine, DTaP 5 -IPV-Hib-HepB 1 , has been accepted for review by the U.S. Food and Drug Administration (FDA). If approved, it would be the first pediatric combination vaccine in the United States designed to help protect against six important diseases – diphtheria, tetanus, pertussis (whooping cough), polio (poliovirus types 1, 2, and 3), invasive disease caused by Haemophilus influenzae type b (Hib), and hepatitis B.
Sign-up for US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine investment picks
TARRYTOWN, N.Y. and PARIS , Oct.
Sign-up for Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis investment picks
Amgen Seeks Injunction Related to PCSK9 Inhibitor THOUSAND OAKS, Calif.
Sign-up for Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Sanofi
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Sanmina Corp  |  Next: ETFS Holding Sanofi Adr